Aging Clinical Trial
Official title:
The Effects of Exercise on Sleep and Brain Health
Verified date | March 2022 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Brain health and cognitive functioning can be affected by aging. Exercise is a potentially effective method for promoting "successful brain aging" by improving cardiovascular fitness, brain function and possibly sleep quality. This project will measure the effects of exercise on brain health and attempt to develop a better way to track brain health, by measuring brain activity during sleep.
Status | Completed |
Enrollment | 26 |
Est. completion date | August 4, 2021 |
Est. primary completion date | August 4, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Sedentary (= two exercise sessions per week for the past 6 months) 2. Aged 50 to 75 years old 3. Cleared by primary care physician or other personal physician to participate in a 12-week moderate-intensity walking exercise program. Clearance can be provided to one of the study investigators either verbally or in writing. Exclusion Criteria: 1. History of neurological illness (e.g. poorly controlled epilepsy with >1 seizure per month in the last 6mo, stroke with residual motor language deficits, Multiple sclerosis, Parkinson's disease, clinically diagnosed dementia [defined as score <26 on the Mini-Mental State Examination], head trauma in the preceding 6-months with continued cognitive symptoms, cerebral palsy, brain tumor, normal-pressure hydrocephalus, HIV infection, or Huntington's disease) 2. Untreated Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I disorders (i.e., severe depressive symptoms, substance abuse or dependence) 3. Impaired activities of daily living (ADLs) measured by the Lawton and Brody Self-Maintaining and Instrumental Activities of Daily Living Scale. 4. Inability to safely exercise or perform any of the tests 5. Inability to perform the cognitive tests due to lack of English proficiency 6. Known diagnosis of severe sleep apnea (apnea-hypopnea index = 15/hour of sleep) 7. Subject fails Cardiopulmonary Exercise Testing (CPET), i.e. develops symptoms such as shortness of breath, chest pain, palpitations, lightheadedness, or syncope during CPET testing 8. Patients with a pacemaker or an automatic implantable cardioverter-defibrillator. |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in EEG-based Brain Age (as measured via the Brain Age Index algorithm) after a 12-week aerobic exercise program. | The Brain Age Index (BAI) algorithm reports how old an individual's sleeping brain activity "looks", called the "brain age" (BA), and compares this with the chronological age (CA). The difference is the Brain Age Index (BAI), which is calculated by subtracting the Chronological Age (CA) from the calculated Brain Age (BA): BAI = BA-CA.
A higher BAI can reflect worse clinical outcomes (e.g. increase mortality risk) while a lower BAI can reflect better clinical outcomes. |
Baseline, 12 weeks | |
Primary | Change from baseline in cognitive performance (as measured via the National Institutes of Health (NIH) Toolbox Cognition battery) after a 12-week aerobic exercise program. | The NIH Toolbox Cognition battery is a composite of 7 tests [Picture Vocabulary (PV), Reading Test (RT), Flanker, Dimensional Change Card Sort (DCCS), Picture Sequence Memory (PSM), List Sorting (LS), Pattern Comparison (PC)] assessing language, receptive vocabulary, executive function, attention, working/short-term/episodic memory, cognitive flexibility, processing speed, prior education, verbal intelligence. Uncorrected, Age-corrected, and Fully-Corrected scores (mean =100,100,50 and StdDev=15,15,10 respectively) are calculated for each test. Composite scores are given for Fluid, Crystallized, and overall Cognitive Function. The Fluid Composite Score is derived by averaging the std. scores of the Flanker, DCCS, PSM, LS and PC tests. The Crystallized Composite Score is derived by averaging the std. scores of the PV & RT. The Cognitive Function Composite Score is derived by averaging the Fluid & Crystallized std. scores. Higher scores indicate higher levels of cognitive functioning. | Baseline, 12 weeks | |
Secondary | Association between brain age index (BAI) and sleep quality (as measured via a home sleep EEG monitoring device). | EEG signals will be collected via a home sleep monitoring device (Prodigy Sleep System) - a portable, wireless, forehead-mounted monitor that utilizes frontal electrodes. From the EEG, sleep depth and fragmentation (markers of sleep quality) will be measured. | Weeks 1-12 | |
Secondary | Association between brain age index (BAI) and sleep quality (as measured via respiration). | Breathing patterns will be measured via a wearable respiratory sensor device (AirGo) as they vary with sleep stage and depth (markers of sleep quality). The Airgo device measures the expansion and recoil of the patient's chest. | Weeks 1-12 | |
Secondary | Association between brain age index (BAI) and pre-existing co-morbidity (as measured via the Charlson Co-morbidity Index). | The Charlson Co-morbidity Index (CCI) assesses 17 categories that together evaluates a patient's ten-year survival. Each co-morbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights result in a single co-morbidity score for a patient. A score of zero indicates that no co-morbidities were found. The higher the score, the more likely the predicted outcome will result in mortality or higher resource use. | Baseline | |
Secondary | Association between brain age index (BAI) and depression (as measured via the Patient Health Questionnaire-2). | The Patient Health Questionnaire scale (PHQ-2) is a 2-item screening measure which ranges from a score of 0 to 6. The higher the score, the more likely there is an underlying depressive disorder. | Baseline | |
Secondary | Association between brain age index (BAI) and anxiety (as measured via the Generalized Anxiety Disorder Questionnaire-2). | The Generalized Anxiety Disorder (GAD-2) is a 2-item screening measure which ranges from a score of 0 to 6. The higher the score, the more likely there is an underlying anxiety disorder. | Baseline | |
Secondary | Association between brain age index (BAI) and diet (as measured via the 14-Q Mediterranean Diet Questionnaire). | The 14-item Mediterranean Diet Adherence Screener (MEDAS) is a brief questionnaire assessing adherence to the Mediterranean diet. It consists of a total of 14 questions that characterize key food groups commonly consumed as part of a traditional Mediterranean diet (12 questions about frequency of food consumption; two questions about food intake habits). Answers are summed to a total Mediterranean diet score ranging from 0 to 14, with higher scores indicating greater adherence. | Baseline | |
Secondary | Association between brain age index (BAI) and social network (as measured via the Social Network Index). | The Cohen's Social Network Index (SNI) assesses the size, diversity, and complexity of a respondent's current social network across 12 types of social relationships. Social network size measures the total number of people with whom the patient has regular contact (at least once every 2 weeks) and is computed by summing across the 12 roles. Social network diversity measures the number of social roles in which the patient has regular with at least 1 person (range 0-12). Social network complexity measures the number of different network domains in which a patient is active (range 0-8). Higher scores represent a larger, more diverse and complex social network. | Baseline | |
Secondary | Association between brain age index (BAI) and social network (as measured via the University of California, Los Angeles Loneliness Scale). | The University of California, Los Angeles (UCLA) Loneliness Scale is a 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation (range 20-80). Higher scores indicate greater degrees of loneliness. | Baseline | |
Secondary | Association between brain age index (BAI) and socioeconomic status (as measured via The Hollingshead Four Factor Index of Social Status). | The Hollingshead Four Factor Index of Social Status (Hollingshead, 1975) use education, occupation, sex, and marital status to determine a family's composite social status. Education scores (range 1-7), occupation codes (range 1-9) are weighted by 3 and 5 respectively. Raw scores range from 8 to 66, with higher scores reflecting higher socioeconomic status. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |